Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Treat Diabetes (US)

Analysis of: FDA Panel To Weigh Heart Trials For Diabetes Meds (www.pharmalot.com)
1. CVD is a major diabetes complication. 2. Recent studies have questioned whether some diabetes drugs increase rather than decrease CVD. 3. The new FDA guidelines place a high burden on the pharmaceutical industry for developing new diabetes drugs without demonstrable CVD risk.
December 16, 2008
Remember the frying pan?
Analysis of: Scientists back brain drugs for healthy people (www.washingtonpost.com)
This is an abuse of medication - what we don't need
December 15, 2008
Asthma - will this help??
Analysis of: FDA: Long-Acting Asthma Drugs Increase Asthma Risks (online.wsj.com)
Ruling not unreasonable, but may cause confusion to patients.
December 5, 2008
Lipitor sales
Analysis of: Patients Taking Lipitor Had a Significantly Reduced Risk of Cardiovascular Events Compared with Patients Taking Simvastatin, New Observational Study Shows (pharmalive.com)
The results of this observational study suggested Lipitor was more effective than simvastatin.  This is not terribly surprising.  Lipitor is the more potent statin, even allowing for dosing differences.  Observational studies, however, have inherent weaknesses in that...
Analysis of: Patients Taking Lipitor Had a Significantly Reduced Risk of Cardiovascular Events Compared with Patients Taking Simvastatin, New Observational Study Shows (pharmalive.com)
This is an interesting analysis that may be scientifically flawed (because it was based on observational data that is subject to selection, medication compliance and comorbidity biases). It may encourage some prescribers to use Lipitor rather than simvastatin. However, that propensity may continue to...
Analysis of: Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes (content.onlinejacc.org)
This analysis of a completed trial suggests that patients using statins plus ezetimibe to achieve an LDL of under 70, had better regression of atherosclerosis than patients with an LDL target of under 100. In addition, the ezetimibe plus statin group did just as well as a group that used statins alone...
Analysis of: Personal medicine is goal of Eli Lilly & Co. (www.azcentral.com)
The article indicates that medications will be designed to be effective for particular populations.  This will prevent the need to try medications which are effective for 50% of the population or less.
Analysis of: Are Costly Diabetes Pills Doing Any Good? (www.pharmalot.com)
1. Yes, more expensive glucose-lowering drugs are being more widely used. 2. No, I do not think that medical evidence suggests that this is incorrect.
Carlos Dujovne, MD, Professor of Medicine and Director
Carlos Dujovne, MD, Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study (www.astrazeneca.com)
1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...
Analysis of: C. Difficile And Antibiotics Not Necessarily Linked, Study Finds (www.sciencedaily.com)
C. difficile is only linked to antibiotic use about half the time.  In addition c. difficile can complicate IBS more that previously thought.  This may be why antibiotics that cover c. difficile have been useful in treating irritable bowel syndrome.  

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 235

Analytics


Generated at 2009-01-07T19:00:58.307